Social Determinants of Health Needs More Likely for Patients With ED Encounters
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Dec. 20, 2023 -- Patients with emergency department encounters are more likely to screen positive for social determinants of health (SDOH) needs, according to a research letter published online Dec. 19 in JAMA Network Open.
Stacie Vilendrer, M.D., M.S.P.H., from the Stanford University School of Medicine in California, and colleagues conducted a cross-sectional study to explore the characteristics of patients who are screened and screen positive for SDOH needs in different clinical settings in a large health system. Systemwide standardized SDOH screens were administered in Intermountain Healthcare primary care clinics and emergency departments between Sept. 1, 2019, and Dec. 31, 2020.
During the study period, 16.7 percent of 2,058,836 in-person primary care encounters, 8.0 percent of 389,789 virtual primary care encounters, and 0.2 percent of 383,596 emergency department encounters were screened. The researchers found that relative to all encounters, emergency department encounters were significantly more likely to reveal SDOH needs (51.6 versus 7.8 percent), despite significantly lower screening rates (0.2 versus 13.3 percent). Married marital status and chronic pulmonary disease or cancer diagnoses were significantly less likely to be associated with positive SDOH screening. Significant associations with having a positive SDOH screen were seen for Hispanic ethnicity, highest area deprivation index, and diagnosis of depression, drug use disorder, or obesity.
"Our study found that patients screened in the emergency department were more likely to screen positive for SDOH needs, which is not surprising given utilization patterns," the authors write.
One author disclosed ties to Johnson & Johnson.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-21 02:15
Read more
- FDA Approves Vyalev for Advanced Parkinson Disease
- USPSTF Recommends Providing Interventions to Support Breastfeeding
- Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
- Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
- How a Move Away From Beef Could Help the Planet
- When This Black Cat Crossed His Path, It Was a Lucky Day for Medicine
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions